Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-30 @ 11:33 PM
Study NCT ID:
NCT05465733
Status:
UNKNOWN
Last Update Posted:
2022-07-20
First Post:
2022-07-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-line Replacement Maintenance of Envafolimab in Advanced NSCLC
Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-17
First Submit QC Date:
None
Study First Post Date:
2022-07-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-17
Last Update Post Date:
2022-07-20
Last Update Post Date Type:
ACTUAL